M-alpha-HMCA

From Wikipedia, the free encyclopedia

M-alpha-HMCA
M-alpha-HMCA.png
Identifiers
  • 3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamide
Chemical and physical data
FormulaC13H18N2O4
Molar mass266.13 g/mol (freebase) 239.78 g/mol (hydrochloride) g·mol−1
3D model (JSmol)
  • NC(C(O)(C)C(NC)=O)C1=CC(OCO2)=C2C=C1
  • InChI=InChI=1S/C12H16N2O4/c1-12(16,11(15)14-2)10(13)7-3-4-8-9(5-7)18-6-17-8/h3-5,10,16H,6,13H2,1-2H3,(H,14,15)
  • Key:DOTWAAVOPAQLCB-UHFFFAOYSA-N

M-alpha-HMCA (3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamide) is an unintentional sideproduct during the synthesis of MDMA using PMK glycidate as a precursor. It was identified in MDMA pills.[1] The biological properties of this molecule have not yet been documented. The backbone of the chemical structure is M-alpha whose psychoactive activity has been described by Alexander Shulgin.[citation needed]

References[edit]

  1. ^ Lee JH, Park OR, Mandava S, Kim J, Koo J, Lee J, Kang H (August 2020). "Identification of a new M-ALPHA analog and MDMA in an illegal health product". Forensic Science International. 313: 110332. doi:10.1016/j.forsciint.2020.110332. PMID 32540761.